Anemia News and Research

RSS
Anemia is a decrease in normal number of red blood cells (RBCs) or less than the normal quantity of hemoglobin in the blood. However, it can include decreased oxygen-binding ability of each hemoglobin molecule due to deformity or lack in numerical development as in some other types of hemoglobin deficiency. The three main classes of anemia include excessive blood loss (acutely such as a hemorrhage or chronically through low-volume loss), excessive blood cell destruction (hemolysis) or deficient red blood cell production (ineffective hematopoiesis). Anemia is the most common disorder of the blood. There are several kinds of anemia, produced by a variety of underlying causes. Anemia can be classified in a variety of ways, based on the morphology of RBCs, underlying etiologic mechanisms, and discernible clinical spectra, to mention a few.
U.S. District Court rules in favor of Alnylam in patent infringement case against Tekmira

U.S. District Court rules in favor of Alnylam in patent infringement case against Tekmira

InterCure signs strategic service agreement with private company

InterCure signs strategic service agreement with private company

Study unlocks secrets in bone marrow that could lead to improved treatments for colitis, Crohn's

Study unlocks secrets in bone marrow that could lead to improved treatments for colitis, Crohn's

Bone marrow transplants hold promise for sickle cell patients

Bone marrow transplants hold promise for sickle cell patients

Even partially matched bone marrow transplants can eliminate sickle cell disease in some patients

Even partially matched bone marrow transplants can eliminate sickle cell disease in some patients

Partially-matched bone marrow transplants can eliminate sickle cell disease in some patients

Partially-matched bone marrow transplants can eliminate sickle cell disease in some patients

Partially-matched bone marrow transplants can eliminate sickle cell disease in some patients

Partially-matched bone marrow transplants can eliminate sickle cell disease in some patients

Antiwasting supplements provide moderate improvements in child health

Antiwasting supplements provide moderate improvements in child health

FDA warns consumers not to use Intestinomicina for treatment of infectious diarrhea

FDA warns consumers not to use Intestinomicina for treatment of infectious diarrhea

Positive data from Nektar’s NKTR-192 Phase 1a study on acute pain

Positive data from Nektar’s NKTR-192 Phase 1a study on acute pain

Researchers to probe causes, treatments of toxic reactions in blood plasma

Researchers to probe causes, treatments of toxic reactions in blood plasma

Parents of sickle cell babies undercounseled

Parents of sickle cell babies undercounseled

ASN's top five recommendations to avoid wasteful and harmful medical interventions

ASN's top five recommendations to avoid wasteful and harmful medical interventions

IPS examines controversy over WHO-approved drug to prevent hemorrhage after labor

IPS examines controversy over WHO-approved drug to prevent hemorrhage after labor

Combination chemotherapy confirmed viable for penile cancer

Combination chemotherapy confirmed viable for penile cancer

Parents of infants with cystic fibrosis carriers more likely to receive genetic counseling

Parents of infants with cystic fibrosis carriers more likely to receive genetic counseling

Scripps scientists discover new antibody-discovery technique

Scripps scientists discover new antibody-discovery technique

Many pediatric respiratory hospitalizations unnecessary

Many pediatric respiratory hospitalizations unnecessary

Data from Sangamo BioSciences’ SB-728-T Phase 1 clinical programs on HIV/AIDS

Data from Sangamo BioSciences’ SB-728-T Phase 1 clinical programs on HIV/AIDS

Distribution infrastructure, effective education important for success of micronutrient powders to treat childhood anemia

Distribution infrastructure, effective education important for success of micronutrient powders to treat childhood anemia

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.